Skip to main content
. Author manuscript; available in PMC: 2010 Nov 8.
Published in final edited form as: Transplantation. 1994 Mar 27;57(6):848–851. doi: 10.1097/00007890-199403270-00013

Table 2.

Causes of early and late morbidity following lung TX in a randomized trial of FK506 vs. CsA

Group Mortality (≤30 days) Cause of death (n)
Early
 FK506 3% (1/38) Toxoplasmosis (1)
 CsA 6% (2/36) Bacterial pneumonia (1)
Cardiac arrest (1)
Late
 FK506 13% (5/38) P aeruginosa pneumonia (2)
Adenoviral pneumonia (2)
CMV pneumonia (1)
 CsA 16% (6/36) P aeruginosa pneumonia (3)
Adenoviral pneumonia (1)
PTLD (1)
Respiratory failure (reason unknown) (1)